It is suggested that the saporin-conjugated anti-Robo1 immunotoxin comprises a novel therapeutic target in HNSCC by the application of saponin, and the drug delivery system developed here should prove to be applicable to other cancer targets. Here, ROBO1 is linked to head and neck squamous cell carcinoma.